Market News AIOpen the app

IPHA stock news · Innate Pharma

Stories about Innate Pharma (IPHA) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IPHA

Follow Innate Pharma (IPHA) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for IPHA
Free on the App Store and Google Play, or on the web.
  1. Nov 19, 2026, 3:06 AM ET · Trial

    Innate Pharma shared early Phase 1 study results for IPH4502, showing it fights tumors and has stable linkers.

    Neutral

    Innate Pharma shared early IPH4502 trial observations and a linker-stability milestone, but gave no response figures or explained their effect. This does not yet change how we read the company.

  2. Oct 21, 2026, 3:07 AM ET · Market

    Innate Pharma will join two healthcare conferences to talk with investors.

    Neutral

    Innate Pharma will attend 2 healthcare conferences to discuss its immunotherapy pipeline. The story reports no new results or company changes, so it does not change the company's outlook.